Saltar al contenido
Merck

Bacteremia due to imipenem-resistant Roseomonas mucosa in a child with acute lymphoblastic leukemia.

Journal of pediatric hematology/oncology (2013-05-15)
Anne-Laure Michon, Laure Saumet, Alice Bourdier, Stéphanie Haouy, Nicolas Sirvent, Hélène Marchandin
RESUMEN

Roseomonas are described as opportunistic pathogens rarely involved in human infections. Their identification requires molecular methods and their antimicrobial susceptibility pattern varies according to the species. We report the first case of bacteremia due to Roseomonas mucosa in a child with leukemia and reviewed pediatric cases of Roseomonas infection, for which undoubted strain identification was available. Favorable outcome was observed despite resistance to numerous β-lactams that may account for delayed effective treatment, suggesting the low virulence of Roseomonas in children. Here, the strain also displayed unusual resistance to imipenem, highlighting the possible acquisition of additional resistance by this pathogen.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Imipenem monohydrate, ≥98% (HPLC)